Prediction of the Effects of Renal Impairment on Clearance for Organic Cation Drugs that Undergo Renal Secretion: A Simulation-Based Study-Reference-Cited by-同舟云学术

Prediction of the Effects of Renal Impairment on Clearance for Organic Cation Drugs that Undergo Renal Secretion: A Simulation-Based Study

Published:2018-02-28 Issue:5 Volume:46 Page:758-769
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Follman Kristin E.,Morris Marilyn E.^ORCID

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference35 articles.

1. Metformin and cimetidine: physiologically based pharmacokinetic modelling to investigate transporter mediated drug-drug interactions;Burt;Eur J Pharm Sci,2016

2. Proximal Tubular Secretion of Creatinine by Organic Cation Transporter OCT2 in Cancer Patients

3. The effect of renal function on the pharmacokinetics of ranitidine;Dixon;Eur J Clin Pharmacol,1994

4. The effect of chronic renal failure on drug metabolism and transport

5. FDA (2010) Guidance for Industry Pharmacokinetics in Patients with Impaired Renal Function — Study Design, Data Analysis, and Impact on Dosing and Labeling, U.S. Department of Health and Human Services Food and Drug Administration, Silver Spring, MD.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incorporating Uremic Solute-mediated Inhibition of OAT1/3 Improves PBPK Prediction of Tenofovir Renal and Systemic Disposition in Patients with Severe Kidney Disease;Pharmaceutical Research;2023-09-13

2. Understanding Statin‐Roxadustat Drug–Drug‐Disease Interaction Using Physiologically‐Based Pharmacokinetic Modeling;Clinical Pharmacology & Therapeutics;2023-07-13

3. Predicting transporter mediated drug–drug interactions via static and dynamic physiologically based pharmacokinetic modeling: A comprehensive insight on where we are now and the way forward;Biopharmaceutics & Drug Disposition;2022-12-14

4. Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective;Clinical Pharmacology & Therapeutics;2022-06-21

5. Effect of Chronic Kidney Disease on the Renal Secretion via Organic Anion Transporters 1/3: Implications for Physiologically‐Based Pharmacokinetic Modeling and Dose Adjustment;Clinical Pharmacology & Therapeutics;2022-06-13